Clinical Trial Update: A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial assessing fixed-dose ropinirole prolonged-release as adjunctive therapy in advanced Parkinson's disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole prolonged-release (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-12-03